The Effect Coenzyme Q10 on cardiac complacation after chemotherapy

Not Applicable

Recruiting

• Conditions: Condition 1: Lymphoblastic Leukemia. Condition 2: Hodgkin Lymphoma.; Lymphoid leukaemia; Hodgkin lymphoma

• Registration Number: IRCT2016101026390N3
• Lead Sponsor: Ahwaz Jundishapour University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

age between 1 and 16 years old; normal kidney and liver function; malignancy and under treatment with antracyclines; LVEF deterioration between 30 and 40%. Exclusion criteria: food supplement or other dietary regimen; congenital heart disease; other systemic disease other than cancer.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eft Ventricular Chamber Volume. Timepoint: Before and after intervention. Method of measurement: Echocardiography.;Left Ventricular End Diastolic Diameter. Timepoint: Before and after intervention. Method of measurement: Echocardiography.;Left Ventricular End Systolic Diameter. Timepoint: Before and after intervention. Method of measurement: Echocardiography.;Left Ventricular Ejection Fraction. Timepoint: Before and after intervention. Method of measurement: Echocardiography.;Left Ventricular Fraction Shortening. Timepoint: Before and after intervention. Method of measurement: Echocardiography.;Electrocardiogram iterpretion. Timepoint: Before and after intervention. Method of measurement: Electrocardiogram.

Secondary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before and after intervention. Method of measurement: Sensitive Scale.